Advertisement

Health


ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

Earlier this year a Byron Bay-based company achieved a milestone ...

Could new findings put Mesoblast back in the COVID treatment race?

Could new findings put Mesoblast back in the COVID treatment race?

After four months in the doldrums due to its COVID-19 treatment i...

AnteoTech launches 15-minute COVID-19 test in Europe

AnteoTech launches 15-minute COVID-19 test in Europe

Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

Advertisement
Advertisement
Advertisement
Aussies to wait for now as UK starts rolling out Pfizer vaccine

Aussies to wait for now as UK starts rolling out Pfizer vaccine

The UK may be ready to roll out the new Pfizer-BioNTech COVID-19 ...

FDA fast tracks Mesoblast COVID-19 treatment

FDA fast tracks Mesoblast COVID-19 treatment

A COVID-19 treatment being developed by Australian pharmaceutical...

Viva Leisure raises $30m to pump up as gym junkies return in droves

Viva Leisure raises $30m to pump up as gym junkies return in droves

As gym junkies return in droves to its centres, Viva Leisure (ASX: ...

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Australian pharmaceutical company Mesoblast (ASX: MSB) has penned...

Pfizer COVID-19 vaccine now 95 per cent effective

Pfizer COVID-19 vaccine now 95 per cent effective

A COVID-19 vaccine candidate being developed by US pharmaceutical...

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Althea gets green light to sell Australian-made medicinal cannabis in Germany

Melbourne-based Althea Group (ASX: AGH) is on track to becoming t...

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Smiles Inclusive (ASX: SIL) joint venture partners (JVPs) have ha...

CSL to build $800m flu vaccine facility in Melbourne

CSL to build $800m flu vaccine facility in Melbourne

Australia-headquartered CSL (ASX: CSL) is set to bring a cell-bas...

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

A COVID-19 vaccine being developed by the University of Queenslan...

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

The improving COVID-19 situation in Victoria and New South Wales ...

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Melbourne-based med-tech company Mesoblast (ASX: MSB) has rebound...

Health fund backs medicinal cannabis with Little Green Pharma deal

Health fund backs medicinal cannabis with Little Green Pharma deal

Little Green Pharma (ASX: LGP) hopes a new strategic partnership ...

Smiles Inclusive enters voluntary administration

Smiles Inclusive enters voluntary administration

The local anaesthetic of turnaround promises has finally wor...

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to ...

Healthia to buy The Optical Company for $43 million

Healthia to buy The Optical Company for $43 million

Just one day after announcing yet another spending spree, allied ...

Advertisement

Partner Content

Australian businesses could be losing billions of dollars due to ...
With many innovative functions like copy trading, crypto investme...
Whilst some cannabis stocks can trade on hype and future earnings...
The focus on digital health has become a global trend. The long...
Food Revolution Group (ASX: FOD) could be the ASX's turnaroun...
A big shift in consumer spending habits over the past year has pl...
It took determination and ambition for Glen Richards to scale up ...
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
Advertisement